Article Text
PDFImage of the moment
Capecitabine leukoencephalopathy
Statistics from Altmetric.com
Footnotes
Contributors ZY and MSO contributed to the original write-up of the manuscript. ZY, RB and BS contributed to patient care and revision of the manuscript in their respective specialty. RB provided the high-quality images and the figure captions.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned. Externally peer reviewed by Jeremy Rees, London, UK.
Read the full text or download the PDF:
Other content recommended for you
- Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients
- What to see when you are looking at confusion: a review of the neuroimaging of acute encephalopathy
- Cortical abnormalities on MRI: what a neurologist should know
- Persistent lesion hyperintensity on brain diffusion-weighted MRI is an early sign of intravascular lymphoma
- Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings
- Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose
- A review of structural magnetic resonance neuroimaging
- Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging
- Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia
- Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)